Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort

18 Jan 2017Anick Bérard, Jinping Zhao and Odile Sheehy.

Antidepressants with effects on serotonin reuptake during embryogenesis increased the risk of some organ-specific malformations in a cohort of pregnant women with depression.

Cohort Study
1 effect
3 months
18 subjects

Reported Outcomes

DeterminantsOutcomeDetails

Antidepressants Manufactured risk & protective factor
Strong Risk Factor Antidepressants
Manufactured

Congenital Anomaly Maternity outcome
Strong increased risk of Congenital Anomaly
Maternity system

High evidence
155.0%